Millennium Management’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $183K | Sell |
13,705
-219,498
| -94% | -$2.93M | ﹤0.01% | 3725 |
|
|
2025
Q1 | $2.38M | Sell |
233,203
-644,956
| -73% | -$6.57M | ﹤0.01% | 2486 |
|
|
2024
Q4 | $13.9M | Buy |
878,159
+305,169
| +53% | +$4.83M | 0.01% | 1337 |
|
|
2024
Q3 | $33.3M | Buy |
572,990
+180,034
| +46% | +$10.5M | 0.02% | 790 |
|
|
2024
Q2 | $18M | Buy |
392,956
+55,293
| +16% | +$2.53M | 0.01% | 1140 |
|
|
2024
Q1 | $22.4M | Sell |
337,663
-184,465
| -35% | -$12.2M | 0.01% | 1000 |
|
|
2023
Q4 | $20.8M | Buy |
522,128
+318,071
| +156% | +$12.6M | 0.01% | 1008 |
|
|
2023
Q3 | $6.51M | Buy |
204,057
+164,161
| +411% | +$5.23M | ﹤0.01% | 1705 |
|
|
2023
Q2 | $1.6M | Buy |
39,896
+15,523
| +64% | +$624K | ﹤0.01% | 2652 |
|
|
2023
Q1 | $1.04M | Sell |
24,373
-156,904
| -87% | -$6.7M | ﹤0.01% | 3010 |
|
|
2022
Q4 | $8.71M | Buy |
+181,277
| New | +$8.71M | ﹤0.01% | 1697 |
|
|
2022
Q2 | – | Sell |
-65,688
| Closed | -$3.57M | – | 5334 |
|
|
2022
Q1 | $3.57M | Buy |
65,688
+12,944
| +25% | +$704K | ﹤0.01% | 2597 |
|
|
2021
Q4 | $3.09M | Sell |
52,744
-129,132
| -71% | -$7.56M | ﹤0.01% | 2612 |
|
|
2021
Q3 | $7.2M | Buy |
181,876
+64,961
| +56% | +$2.57M | ﹤0.01% | 1826 |
|
|
2021
Q2 | $4.97M | Sell |
116,915
-13,350
| -10% | -$567K | ﹤0.01% | 2146 |
|
|
2021
Q1 | $8.02M | Buy |
130,265
+42,309
| +48% | +$2.6M | 0.01% | 1607 |
|
|
2020
Q4 | $6.2M | Buy |
87,956
+79,217
| +906% | +$5.59M | ﹤0.01% | 1735 |
|
|
2020
Q3 | $337 | Buy |
+8,739
| New | +$337 | ﹤0.01% | 3013 |
|